These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1344968)

  • 21. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.
    Bowman RJ; Sillah A; Van Dehn C; Goode VM; Muqit MM; Johnson GJ; Milligan P; Rowley J; Faal H; Bailey RL
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4074-9. PubMed ID: 11095598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular epidemiology of ocular Chlamydia trachomatis infections in Western Australia: implications for trachoma control.
    Porter M; Mak D; Chidlow G; Harnett GB; Smith DW
    Am J Trop Med Hyg; 2008 Mar; 78(3):514-7. PubMed ID: 18337352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of Chlamydia trachomatis types in children with clinical trachoma in New Delhi, India.
    Kumar VN; Sujata M; Satpathy G
    Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1991; 68():129-44. PubMed ID: 1669643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of diseases caused by Chlamydia organisms.
    Dawson C
    Int Ophthalmol Clin; 1973; 13(4):93-101. PubMed ID: 4593599
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality assessment of conjunctival specimens for detection of Chlamydia trachomatis by PCR in children with active trachoma.
    de Barbeyrac B; Goldschmidt P; Malembic S; Raherison S; Clerc M; Bodaghi B; Bébéar C; Chaumeil C
    Clin Microbiol Infect; 2007 Jul; 13(7):689-94. PubMed ID: 17441975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current trends in trachoma in a previously hyperendemic area. The Trachoma Study Group.
    Indian J Ophthalmol; 1998 Dec; 46(4):217-20. PubMed ID: 10218304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chlamydia trachomatis immunotypes in trachoma epidemic areas of north China].
    Zhang L
    Zhonghua Yan Ke Za Zhi; 1991 Mar; 27(2):67-70. PubMed ID: 1860405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isolation of Chlamydia trachomatis in trachomatous Moroccan patients].
    Takourt B; Milad A; Radouani F; Boura H; Guinet R; Benslimane A
    J Fr Ophtalmol; 1996; 19(8-9):527-32. PubMed ID: 8944135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Course of trachoma under treatment with 1% oxytetracycline ophthalmic solution].
    Resnikoff S; Castan R; Peyramaure F; Bagayogo C; Huguet P
    J Fr Ophtalmol; 1994; 17(10):591-5. PubMed ID: 7822697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type-specific antibodies in human Chlamydia trachomatis infections of the eye.
    Briones OC; Hanna L; Jawetz E; Dawson CR; Ostler HB
    J Immunol; 1974 Oct; 113(4):1262-70. PubMed ID: 4138029
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole.
    Sheng WD; Jiddawi MS; Hong XQ; Abdulla SM
    East Afr Med J; 1997 May; 74(5):283-4. PubMed ID: 9337003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drug for the treatment of trachoma (clinical trial report).
    Hasan MM
    Rev Int Trach Pathol Ocul Trop Subtrop; 1976; 53(3-4):105-17. PubMed ID: 1028123
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rifadin activity in trachoma and paratrachoma].
    Terskikh II; Kudoiarov GKh; Semenova EN; Chemodanova LE; Ianbukhtina FA
    Vopr Virusol; 1976; (6):721-4. PubMed ID: 1030904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TREATMENT OF TRACHOMA.
    CHHIBBER PR
    Indian Med J; 1964 Jan; 58():3-8. PubMed ID: 14112177
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intermittent treatment of trachoma by means of sulfamethoxypyrazine].
    Milano C
    Boll Ocul; 1965 Dec; 44(12):955-62. PubMed ID: 5884906
    [No Abstract]   [Full Text] [Related]  

  • 39. [Albucid in therapy of the trachoma and its complications].
    TSOPELAS B
    Klin Monbl Augenheilkd Augenarztl Fortbild; 1952; 120(2):173-9. PubMed ID: 14939564
    [No Abstract]   [Full Text] [Related]  

  • 40. [2-sulfanilamido-3-methoxypyridazine (Kelfizin) in the therapy of trachoma].
    Mazzola U
    Boll Ocul; 1968 Jun; 47(6):417-24. PubMed ID: 5720896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.